PGC-1β maintains mitochondrial metabolism and restrains inflammatory gene expression

• Published in: Scientific reports Vol. 12; no. 1; pp. 16028 - 14
• Main Authors: Guak, Hannah, Sheldon, Ryan D., Beddows, Ian, Vander Ark, Alexandra, Weiland, Matthew J., Shen, Hui, Jones, Russell G., St-Pierre, Julie, Ma, Eric H., Krawczyk, Connie M.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26.09.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/250; 631/250/2504; 631/80; Bioenergetics; Dendritic cells; Electron transport; Gene expression; Glycolysis; Humanities and Social Sciences; Inflammation; Lipopolysaccharides; Metabolism; Mitochondria; multidisciplinary; Oxidative phosphorylation; Phosphorylation; Science; Science (multidisciplinary); β-Interferon
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-20215-6

Metabolic programming of the innate immune cells known as dendritic cells (DCs) changes in response to different stimuli, influencing their function. While the mechanisms behind increased glycolytic metabolism in response to inflammatory stimuli are well-studied, less is known about the programming of mitochondrial metabolism in DCs. We used lipopolysaccharide (LPS) and interferon-β (IFN-β), which differentially stimulate the use of glycolysis and oxidative phosphorylation (OXPHOS), respectively, to identify factors important for mitochondrial metabolism. We found that the expression of peroxisome proliferator-activated receptor gamma co-activator 1β (PGC-1β), a transcriptional co-activator and known regulator of mitochondrial metabolism, decreases when DCs are activated with LPS, when OXPHOS is diminished, but not with IFN-β, when OXPHOS is maintained. We examined the role of PGC-1β in bioenergetic metabolism of DCs and found that PGC-1β deficiency indeed impairs their mitochondrial respiration. PGC-1β-deficient DCs are more glycolytic compared to controls, likely to compensate for reduced OXPHOS. PGC-1β deficiency also causes decreased capacity for ATP production at steady state and in response to IFN-β treatment. Loss of PGC-1β in DCs leads to increased expression of genes in inflammatory pathways, and reduced expression of genes encoding proteins important for mitochondrial metabolism and function. Collectively, these results demonstrate that PGC-1β is a key regulator of mitochondrial metabolism and negative regulator of inflammatory gene expression in DCs.